Acetohexamide
| Systematic (IUPAC) name | |
|---|---|
| 4-acetyl-N-(cyclohexylcarbamoyl)benzenesulfonamide | |
| Clinical data | |
| Trade names | Dymelor |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| MedlinePlus | a602021 |
| Pregnancy cat. | ? |
| Legal status | ? |
| Pharmacokinetic data | |
| Protein binding | 90% |
| Identifiers | |
| CAS number | 968-81-0 |
| ATC code | A10BB31 |
| PubChem | CID 1989 |
| DrugBank | APRD00773 |
| ChemSpider | 1912 |
| UNII | QGC8W08I6I |
| KEGG | D00219 |
| ChEBI | CHEBI:28052 |
| ChEMBL | CHEMBL1589 |
| Chemical data | |
| Formula | C15H20N2O4S |
| Mol. mass | 324.395 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
Acetohexamide (trade name Dymelor) is a first-generation sulfonylurea medication used to treat diabetes mellitus type 2, particularly in people whose diabetes cannot be controlled by diet alone.
[edit] Mechanism of action
Acetohexamide lowers blood sugar by stimulating the pancreas to secrete insulin and helping the body use insulin efficiently.[1] The pancreas must produce insulin for this medication to work. For this reason, acetohexamide is not used to treat diabetes mellitus type 1.
metabolic reduction of acetohexamide into the active hypoglycemic metabolite S-(-)-hydroxyhexamide is carried out by cytochromes
[edit] Risks
Oral hypoglycemic drugs, including acetohexamide, have been associated with increased cardiovascular mortality. Talk to your doctor about the possible risks, benefits, and alternatives of using this drug for your condition.[2]
[edit] References
- ^ [1] - Metformin Side Effects
- ^ Medline Plus - Acetohexamide
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |